Capsovision, INC Form 4 insider transactions

CapsoVision Director Tsai Chen Lung acquired 2,887 shares of common stock through the vesting of Restricted Stock Units.

CapsoVision, Inc. granted 165,000 stock options to Senior VP of Finance David Michael Garcia with an exercise price of $4.78, vesting over four years.

CapsoVision Director Chen Lung Tsai was granted 2,887 Restricted Stock Units, scheduled to vest on December 31, 2025.

CapsoVision Director Hui Ying Kuo was granted 2,887 Restricted Stock Units, aligning her interests with shareholders, with vesting scheduled for December 31, 2025.

CapsoVision, Inc. Director Wen-Herng Henry King received an award of 2,887 Restricted Stock Units, scheduled to vest by December 31, 2025.

CapsoVision Director Joanne Imperial received a grant of 2,887 Restricted Stock Units, scheduled to vest by December 31, 2025.

CapsoVision Director Julia S. Gouw acquired 2,887 Restricted Stock Units, scheduled to vest on December 31, 2025, under a Rule 10b5-1 plan.

CapsoVision Director Michele Harari acquired 2,887 Restricted Stock Units and holds 56,156 common shares following a recent reverse stock split and IPO.

CapsoVision's Director of Clinical Affairs exercised stock options for 24,834 shares following a reverse stock split and IPO.

Eliyahou Harari, a Director and 10% owner of CapsoVision, Inc., reported the automatic conversion of millions of preferred shares into common stock following the company's initial public offering and a reverse stock split.

Eliyahou Harari, a Director and 10% owner of CapsoVision, Inc., reported the conversion of millions of preferred shares into common stock following the company's initial public offering and a reverse stock split.

CapsoVision, Inc. Director Wen-Herng Henry King converted 68,966 shares of Series H Preferred Stock into 20,710 shares of Common Stock following the company's initial public offering and a reverse stock split.

CapsoVision Director Hui Ying Kuo converted 34,482 shares of Series H Preferred Stock into 10,354 shares of Common Stock on July 3, 2025, following the company's initial public offering and a reverse stock split.

CapsoVision, Inc. Director Chen Lung Tsai converted various series of preferred stock into common shares, increasing his indirect beneficial ownership to 115,456 common shares following the company's initial public offering and a 1-for-3.33 reverse stock split.

CapsoVision, Inc. CEO Kang-Huai Wang converted all his preferred stock holdings into common shares following the company's initial public offering, now beneficially owning 721,732 common shares.